SHANGHAI, CHINA / ACCESS Newswire / July 22, 2025 / Lingyi Biotech , a clinical-stage biotechnology company specializing in ...

Treatment with ambroxol for symptoms of Parkinson’s disease dementia was safe, but its efficacy was undetermined in a small ...

The sector is expected to hit $553.8m by 2034. The growing integration of genetic testing into national healthcare frameworks ...

Prajwal's Early Struggles with Gaucher Disease Prajwal, who is now 17 years old and from Bangalore, was diagnosed with Gaucher disease several months after birth.

Spur Therapeutics Publishes Preclinical Proof-of-Concept Data for FLT201, its Clinical-Stage Gene Therapy Candidate in Gaucher Disease ...

Understanding Gaucher Disease Summary Gaucher disease is a rare genetic disorder caused by a deficiency of the enzyme glucocerebrosidase, leading to the buildup of fatty substances in organs and bones ...

An innovative genetic treatment for Gaucher disease has shown promise in mouse models, increasing lifespan and preserving motor function.

Once I saw the hematologist, I went through three straight weeks of testing. The hematology specialist conducted pet scans, CT scans, and a bone marrow biopsy (during which they chip a piece of bone ...

Explore the significant advancements in early diagnosis and treatment of Gaucher disease, a common lysosomal storage disorder, and learn how Sanofi South Africa is working towards improving ...

People with the rare inherited metabolic disorder Gaucher disease have a deficiency in the lipid-digesting glucocerebrosidase enzyme, which causes the accumulation of harmful levels of glucolipids in ...